Source : http://agenabio.com/
Agena Bioscience (Agena) and Simcere Diagnostics (Simceredx), the subsidiary of SIMCERE Pharmaceutical Group, announced the signing of a strategic partnership agreement focusing on expanding the use of Agena’s MassARRAY System for companion diagnostics and pharmacogenetic testing in China.
As a leading pharmaceutical company with strong connections to China’s top tier hospitals, Simcere Diagnostics will concentrate on plans to expand into the field of pharmacogenetic testing, and to develop panels to support companion diagnostics for their drug development pipelines. Supported by a sales organization of 2,000+, Simcere Diagnostics will utilize Agena’s high throughput 384-automated system to support anticipated volumes.
Simceredx will be supported by Agena’s commercial operations team in China, which recently doubled in size due to the growth in the region.
Visit for More Reports on In Vitro Diagnostics : http://www.dpiresearch.com/